Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

NCT00402558 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome
Leukemia

Interventions

DRUG: Thymoglobulin
DRUG: Busulfan
DRUG: Fludarabine
PROCEDURE: Alloreactive NK Infusion
DRUG: G-CSF
DRUG: Tacrolimus
DRUG: Methotrexate
DRUG: Interleukin-2

Sponsor

M.D. Anderson Cancer Center